BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 25673670)

  • 1. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
    Osto E; Doytcheva P; Corteville C; Bueter M; Dörig C; Stivala S; Buhmann H; Colin S; Rohrer L; Hasballa R; Tailleux A; Wolfrum C; Tona F; Manz J; Vetter D; Spliethoff K; Vanhoutte PM; Landmesser U; Pattou F; Staels B; Matter CM; Lutz TA; Lüscher TF
    Circulation; 2015 Mar; 131(10):871-81. PubMed ID: 25673670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Vascular c-Jun N-Terminal Kinase 2 Improves Obesity-Induced Endothelial Dysfunction After Roux-en-Y Gastric Bypass.
    Doytcheva P; Bächler T; Tarasco E; Marzolla V; Engeli M; Pellegrini G; Stivala S; Rohrer L; Tona F; Camici GG; Vanhoutte PM; Matter CM; Lutz TA; Lüscher TF; Osto E
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29138180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric surgery: "Roux"-minating on endothelial cell and high-density lipoprotein function.
    Brown JD
    Circulation; 2015 Mar; 131(10):845-7. PubMed ID: 25673671
    [No Abstract]   [Full Text] [Related]  

  • 4. GLP-1 and PYY
    Dischinger U; Corteville C; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
    Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
    Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
    J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
    Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
    Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
    Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
    Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
    Abegg K; Schiesser M; Lutz TA; Bueter M
    Physiol Behav; 2013 Sep; 121():70-8. PubMed ID: 23562866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.
    Chambers AP; Jessen L; Ryan KK; Sisley S; Wilson-Pérez HE; Stefater MA; Gaitonde SG; Sorrell JE; Toure M; Berger J; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
    Gastroenterology; 2011 Sep; 141(3):950-8. PubMed ID: 21699789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats.
    Davis JF; Schurdak JD; Magrisso IJ; Mul JD; Grayson BE; Pfluger PT; Tschöp MH; Seeley RJ; Benoit SC
    Biol Psychiatry; 2012 Sep; 72(5):354-60. PubMed ID: 22444202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
    Zhang S; Guo W; Wu J; Gong L; Li Q; Xiao X; Zhang J; Wang Z
    Med Sci Monit; 2017 May; 23():2151-2158. PubMed ID: 28477035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
    Werling M; Vincent RP; Cross GF; Marschall HU; Fändriks L; Lönroth H; Taylor DR; Alaghband-Zadeh J; Olbers T; Le Roux CW
    Scand J Gastroenterol; 2013 Nov; 48(11):1257-64. PubMed ID: 24044585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.